EUVIMEDEUVIMED entdecken
Crossref

Biomimetic PtPd nanozyme induce glutamylcysteine synthetase inhibition for enhanced radioimmunotherapy

Huangang Jiang, Hongyang Wu, Tengfei Wang, Dazhen Jiang, Tumaresi Ainiwaer, Yufeng Gu, Lingze Hu, Shuokan Ma, Gaili Chen

Microchimica Acta · 2026

DOI: 10.1007/s00604-026-08005-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microchimica Acta, 2026. Verfasst von Huangang Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Hubei Center of…. Hauptthemen laut MEDLINE: Biomimetic Materials, Glutamate-Cysteine Ligase, Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Shanghai YRD Foundation for Innovation in Health Industry, Project of Hubei Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A multi pathway enhanced radiotherapeutic strategy is presented that combines PtPd nanozyme-based reactive oxygen species (ROS) amassment with the inhibition of glutathione (GSH) synthesis mediated by L-buthionine sulfoximine (BSO). To this end a (BSO)-loaded biomimetic PtPd nanozyme system (named CPB) coated with cancer cell membrane (CM) was developed for radiotherapy (RT) sensitization and immunogenic cell death (ICD). The CM guides nanoparticles to specifically bind tumor cells via homologous targeting, and serves as an efficient carrier for BSO, preventing leakage in blood circulation and enabling precise BSO release in tumors. Then, BSO block both the substrate and enzymatic pathways critical for GSH production by inhibiting glutamylcysteine synthetase (γ-GCS). PtPd nanozyme could amplify oxidative stress in tumor microenvironment (TME) by catalyzing hydrogen peroxide to produce hydroxyl radical (·OH). Furthermore, the presence of Pt and Pd in CPB can enhance local RT energy deposition in tumor site. Both in vitro and in vivo experiments showed CPB significantly inhibiting tumor growth with good biocompatibility. This study underscores that robust RT sensitization is attainable by means of inhibiting γ-GCS synthesis while boosting the production of ROS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomimetic MaterialsGlutamate-Cysteine LigaseEnzyme InhibitorsAnimalsHumansPalladiumButhionine SulfoximinePlatinumReactive Oxygen SpeciesMiceCell Line, TumorGlutathioneNanoparticles

Stichwörter der Autor:innen

BSO-loaded biomimetic PtPd nanozymeGlutathioneNanozymeRadiotherapy

Substanzen

Glutamate-Cysteine LigasePalladiumButhionine SulfoximinePlatinumReactive Oxygen SpeciesEnzyme InhibitorsGlutathione

Autor:innen und Institutionen

  • Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Hubei Center of Quality Control for Radiotherapy of Cancer, Zhongnan Hospital of Wuha…
  • Department of Oncology and Hematology, Hubei No.3 People's Hospital of Jianghan University, Wuhan, 430030, China.
  • Second Clinical College, Wuhan University, Wuhan, 430071, China.

Förderung

  • Shanghai YRD Foundation for Innovation in Health Industry
  • Project of Hubei Provincial Health Commission

Zitieren

APA

Jiang, H., Wu, H., Wang, T., Jiang, D., Ainiwaer, T., Gu, Y., Hu, L., Ma, S., & Chen, G. (2026). Biomimetic PtPd nanozyme induce glutamylcysteine synthetase inhibition for enhanced radioimmunotherapy. Microchimica Acta. https://doi.org/10.1007/s00604-026-08005-7

Vancouver

Jiang H, Wu H, Wang T, Jiang D, Ainiwaer T, Gu Y, et al. Biomimetic PtPd nanozyme induce glutamylcysteine synthetase inhibition for enhanced radioimmunotherapy. Microchimica Acta. 2026. doi:10.1007/s00604-026-08005-7

BibTeX
@article{Jiang2026,
  author = {Jiang, Huangang and Wu, Hongyang and Wang, Tengfei and Jiang, Dazhen and Ainiwaer, Tumaresi and Gu, Yufeng and Hu, Lingze and Ma, Shuokan and Chen, Gaili},
  title = {Biomimetic PtPd nanozyme induce glutamylcysteine synthetase inhibition for enhanced radioimmunotherapy},
  journal = {Microchimica Acta},
  year = {2026},
  doi = {10.1007/s00604-026-08005-7}
}
Kostenlos starten →